Mutual Fund Details

HDFC Pharma And Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹14.4820

as on 26 Jul 2024, 11:14 PM

₹0.2490(1.75%)

Last Change

Schemes Managed By

Nikhil Mathur

Investment Performance

would have given a return of

₹1,00,875

₹1,01,687

₹1,12,999

₹1,13,356

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹13,356

Profit (absolute return)

13.36%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

13.36%

In the last 6 months

20.48%

In the last 1 year

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

HDFC Pharma And Healthcare Fund Direct - Growth

as of 30 Jun 2024, 05:30 AM

₹905.44 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1%, if redeemed within 30 days.

1.06%

Expense Ratio

Plan

Growth

1.98%

Cash Holding

Benchmark

BSE Healthcare Index

Scheme Document

View

Benchmark

BSE Healthcare Index

Exit Load

Exit load of 1%, if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Jun 2024

Sort By

Value

Sector

Healthcare

98.02%

₹887.52 Cr

Others

1.98%

₹17.93 Cr

Sectors Holding in this Mutual Fund

as on 30 Jun 2024

Sort By

Value

Sector

Healthcare

98.02%

₹887.52 Cr

Others

1.98%

₹17.93 Cr

Companies Holding in this Mutual Fund

as on 30 Jun 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.55%

₹113.63 Cr

Cipla Ltd.

6.40%

₹57.95 Cr

Lupin Ltd.

5.44%

₹49.26 Cr

Dr. Reddy's Laboratories Ltd.

5.30%

₹47.99 Cr

Gland Pharma Ltd.

4.84%

₹43.82 Cr

Others

65.47%

₹592.79 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Jun 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.55%

₹113.63 Cr

Cipla Ltd.

6.40%

₹57.95 Cr

Lupin Ltd.

5.44%

₹49.26 Cr

Dr. Reddy's Laboratories Ltd.

5.30%

₹47.99 Cr

Gland Pharma Ltd.

4.84%

₹43.82 Cr

Others

65.47%

₹592.79 Cr

View All

Funds in this Category

This fund's returns:

13.36%

Return Duration

3 Months

Quant Healthcare Fund Direct - Growth

UTI Healthcare Fund Direct-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

About HDFC Pharma And Healthcare Fund Direct - Growth

HDFC Pharma And Healthcare Fund Direct - Growth is a Equity mutual fund scheme from HDFC Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Nikhil Mathur. It has an AUM of ₹905.44 Crores and the latest NAV decalared is ₹14.482 as on 27 Jul 2024 at 6:44 am.

HDFC Pharma And Healthcare Fund Direct - Growth scheme return performance is 42.97% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.